Berkley W R Corp boosted its stake in Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC – Free Report) by 75.0% in the third quarter, Holdings Channel reports. The firm owned 173,901 shares of the company’s stock after purchasing an additional 74,543 shares during the quarter. Berkley W R Corp’s holdings in Bellevue Life Sciences Acquisition were worth $1,887,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also bought and sold shares of BLAC. Clear Street LLC raised its position in shares of Bellevue Life Sciences Acquisition by 6,942.6% in the 2nd quarter. Clear Street LLC now owns 8,592 shares of the company’s stock valued at $92,000 after buying an additional 8,470 shares in the last quarter. Quarry LP acquired a new stake in shares of Bellevue Life Sciences Acquisition during the 2nd quarter worth approximately $701,000. Finally, Warberg Asset Management LLC increased its stake in Bellevue Life Sciences Acquisition by 47.1% in the second quarter. Warberg Asset Management LLC now owns 39,781 shares of the company’s stock valued at $429,000 after acquiring an additional 12,741 shares during the last quarter. Institutional investors own 55.30% of the company’s stock.
Bellevue Life Sciences Acquisition Stock Performance
NASDAQ BLAC opened at $11.17 on Friday. The business has a fifty day moving average price of $11.10 and a two-hundred day moving average price of $10.91. Bellevue Life Sciences Acquisition Corp. has a fifty-two week low of $10.43 and a fifty-two week high of $13.40.
About Bellevue Life Sciences Acquisition
Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington.
Featured Articles
- Five stocks we like better than Bellevue Life Sciences Acquisition
- The 3 Best Blue-Chip Stocks to Buy Now
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- Consumer Staples Stocks, Explained
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- The How and Why of Investing in Gold Stocks
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Want to see what other hedge funds are holding BLAC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC – Free Report).
Receive News & Ratings for Bellevue Life Sciences Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellevue Life Sciences Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.